• Je něco špatně v tomto záznamu ?

Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis

JA. Fraser, EG. Worrall, Y. Lin, V. Landre, S. Pettersson, E. Blackburn, M. Walkinshaw, P. Muller, B. Vojtesek, K. Ball, TR. Hupp,

. 2015 ; 427 (8) : 1728-47.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15022888

Mouse double minute 2 (MDM2) has a phosphorylation site within a lid motif at Ser17 whose phosphomimetic mutation to Asp17 stimulates MDM2-mediated polyubiquitination of p53. MDM2 lid deletion, but not Asp17 mutation, induced a blue shift in the λ(max) of intrinsic fluorescence derived from residues in the central domain including Trp235, Trp303, Trp323, and Trp329. This indicates that the Asp17 mutation does not alter the conformation of MDM2 surrounding the tryptophan residues. In addition, Phe235 mutation enhanced MDM2 binding to p53 but did not stimulate its ubiquitination function, thus uncoupling increases in p53 binding from its E3 ubiquitin ligase function. However, the Asp17 mutation in MDM2 stimulated its discharge of the UBCH5a-ubiquitin thioester adduct (UBCH5a is a ubiquitin-conjugating enzyme E2D 1 UBC4/5 homolog yeast). This stimulation of ubiquitin discharge from E2 was independent of the p53 substrate. There are now four known effects of the Asp17 mutation on MDM2: (i) it alters the conformation of the isolated N-terminus as defined by NMR; (ii) it induces increased thermostability of the isolated N-terminal domain; (iii) it stimulates the allosteric interaction of MDM2 with the DNA-binding domain of p53; and (iv) it stimulates a novel protein-protein interaction with the E2-ubiquitin complex in the absence of substrate p53 that, in turn, increases hydrolysis of the E2-ubiquitin thioester bond. These data also suggest a new strategy to disrupt MDM2 function by targeting the E2-ubiquitin discharge reaction.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15022888
003      
CZ-PrNML
005      
20150729111933.0
007      
ta
008      
150709s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jmb.2014.12.011 $2 doi
035    __
$a (PubMed)25543083
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Fraser, Jennifer A $u Institute of Genetics and Molecular Medicine, Cell Signalling Unit, Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh EH8 9YL, United Kingdom.
245    10
$a Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis / $c JA. Fraser, EG. Worrall, Y. Lin, V. Landre, S. Pettersson, E. Blackburn, M. Walkinshaw, P. Muller, B. Vojtesek, K. Ball, TR. Hupp,
520    9_
$a Mouse double minute 2 (MDM2) has a phosphorylation site within a lid motif at Ser17 whose phosphomimetic mutation to Asp17 stimulates MDM2-mediated polyubiquitination of p53. MDM2 lid deletion, but not Asp17 mutation, induced a blue shift in the λ(max) of intrinsic fluorescence derived from residues in the central domain including Trp235, Trp303, Trp323, and Trp329. This indicates that the Asp17 mutation does not alter the conformation of MDM2 surrounding the tryptophan residues. In addition, Phe235 mutation enhanced MDM2 binding to p53 but did not stimulate its ubiquitination function, thus uncoupling increases in p53 binding from its E3 ubiquitin ligase function. However, the Asp17 mutation in MDM2 stimulated its discharge of the UBCH5a-ubiquitin thioester adduct (UBCH5a is a ubiquitin-conjugating enzyme E2D 1 UBC4/5 homolog yeast). This stimulation of ubiquitin discharge from E2 was independent of the p53 substrate. There are now four known effects of the Asp17 mutation on MDM2: (i) it alters the conformation of the isolated N-terminus as defined by NMR; (ii) it induces increased thermostability of the isolated N-terminal domain; (iii) it stimulates the allosteric interaction of MDM2 with the DNA-binding domain of p53; and (iv) it stimulates a novel protein-protein interaction with the E2-ubiquitin complex in the absence of substrate p53 that, in turn, increases hydrolysis of the E2-ubiquitin thioester bond. These data also suggest a new strategy to disrupt MDM2 function by targeting the E2-ubiquitin discharge reaction.
650    _2
$a alosterická regulace $7 D000494
650    _2
$a aminokyselinové motivy $7 D020816
650    _2
$a sekvence aminokyselin $7 D000595
650    _2
$a zvířata $7 D000818
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a lidé $7 D006801
650    _2
$a hydrolýza $7 D006868
650    _2
$a myši $7 D051379
650    _2
$a molekulární sekvence - údaje $7 D008969
650    12
$a bodová mutace $7 D017354
650    _2
$a polyubikvitin $x metabolismus $7 D025821
650    _2
$a konformace proteinů $7 D011487
650    _2
$a terciární struktura proteinů $7 D017434
650    _2
$a protoonkogenní proteiny c-mdm2 $x chemie $x genetika $x metabolismus $7 D051736
650    _2
$a nádorový supresorový protein p53 $x chemie $x metabolismus $7 D016159
650    _2
$a ubikvitin $x metabolismus $7 D025801
650    _2
$a ubikvitin konjugující enzymy $x metabolismus $7 D044763
650    _2
$a ubikvitinace $7 D054875
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Worrall, Erin G $u Institute of Genetics and Molecular Medicine, Cell Signalling Unit, Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh EH8 9YL, United Kingdom.
700    1_
$a Lin, Yao $u Institute of Genetics and Molecular Medicine, Cell Signalling Unit, Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh EH8 9YL, United Kingdom.
700    1_
$a Landre, Vivien $u Institute of Genetics and Molecular Medicine, Cell Signalling Unit, Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh EH8 9YL, United Kingdom.
700    1_
$a Pettersson, Susanne $u Institute of Genetics and Molecular Medicine, Cell Signalling Unit, Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh EH8 9YL, United Kingdom.
700    1_
$a Blackburn, Elizabeth $u Edinburgh Centre for Chemical Biology, University of Edinburgh, Edinburgh EH8 9YL, United Kingdom.
700    1_
$a Walkinshaw, Malcolm $u Edinburgh Centre for Chemical Biology, University of Edinburgh, Edinburgh EH8 9YL, United Kingdom.
700    1_
$a Muller, Petr $u RECAMO, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
700    1_
$a Vojtesek, Borek $u RECAMO, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
700    1_
$a Ball, Kathryn $u Institute of Genetics and Molecular Medicine, Cell Signalling Unit, Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh EH8 9YL, United Kingdom.
700    1_
$a Hupp, Ted R $u Institute of Genetics and Molecular Medicine, Cell Signalling Unit, Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh EH8 9YL, United Kingdom. Electronic address: Ted.Hupp@ed.ac.uk.
773    0_
$w MED00002808 $t Journal of molecular biology $x 1089-8638 $g Roč. 427, č. 8 (2015), s. 1728-47
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25543083 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20150729112019 $b ABA008
999    __
$a ok $b bmc $g 1083227 $s 905881
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 427 $c 8 $d 1728-47 $i 1089-8638 $m Journal of Molecular Biology $n J Mol Biol $x MED00002808
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...